X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14) 14
animals (10) 10
humans (8) 8
rats (8) 8
metabolism (7) 7
cardiomyocytes (6) 6
myocytes, cardiac - metabolism (6) 6
endocrinology & metabolism (5) 5
heart (5) 5
heart cells (5) 5
mice (5) 5
adipose-tissue (4) 4
cells, cultured (4) 4
diabetes (4) 4
genetic aspects (4) 4
male (4) 4
myocytes, cardiac - drug effects (4) 4
pharmacology & pharmacy (4) 4
physiological aspects (4) 4
rats, sprague-dawley (4) 4
viability (4) 4
acute heart-failure (3) 3
calcium-binding proteins - genetics (3) 3
cardiovascular (3) 3
dna-binding proteins - genetics (3) 3
endocrinology (3) 3
female (3) 3
food-intake (3) 3
glucose - metabolism (3) 3
internal medicine (3) 3
medicine & public health (3) 3
nerve tissue proteins - genetics (3) 3
physiology (3) 3
proto-oncogene proteins c-akt - metabolism (3) 3
research (3) 3
rna, messenger - metabolism (3) 3
skeletal-muscle (3) 3
tpc2 (3) 3
abridged index medicus (2) 2
akt (2) 2
analysis (2) 2
animals, newborn (2) 2
apoptosis (2) 2
biochemistry (2) 2
biology (2) 2
body-weight (2) 2
calcium (2) 2
calcium - metabolism (2) 2
cardiovascular diseases (2) 2
cardiovascular system (2) 2
cardiovascular-disease (2) 2
cell biology (2) 2
contractile function (2) 2
fatty acids (2) 2
fatty acids - metabolism (2) 2
gene expression regulation - physiology (2) 2
glucose (2) 2
glucose transporter type 4 - genetics (2) 2
glucose transporter type 4 - metabolism (2) 2
glucose-transporter (2) 2
glycerophospholipids (2) 2
heart failure (2) 2
heart-failure (2) 2
homeostasis (2) 2
hypertrophy (2) 2
identification (2) 2
immunoblotting (2) 2
in-vitro (2) 2
in-vivo (2) 2
insulin-resistance (2) 2
ion channels (2) 2
ischemia (2) 2
lauric acids - metabolism (2) 2
leptin (2) 2
life sciences (2) 2
lipids (2) 2
metabolic syndrome (2) 2
mice, knockout (2) 2
myocardium - metabolism (2) 2
myocytes, cardiac - physiology (2) 2
naadp (2) 2
oxidation (2) 2
phbv (2) 2
protein (2) 2
proteins (2) 2
recombinant human relaxin-2 (2) 2
relaxin (2) 2
reperfusion (2) 2
review (2) 2
rodents (2) 2
science, general (2) 2
serelaxin (2) 2
signal transduction (2) 2
skeletal myoblasts (2) 2
smooth-muscle (2) 2
sphingolipids (2) 2
standard therapy (2) 2
160 kda (1) 1
2-de-maldi-ms (1) 1
3-hydroxybutyrate-co-3-hydroxyvalerate (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Pharmaceutics, ISSN 0378-5173, 09/2019, Volume 568, p. 118519
Poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles (PHBV-NPs) to encapsulate hydrocortisone (HC) for topical ophthalmic administration were prepared... 
PHBV | Polymeric nanoparticles | Topical ophthalmic administration | Hydrocortisone | PHARMACOLOGY & PHARMACY | DRUG-DELIVERY
Journal Article
Life Sciences, ISSN 0024-3205, 11/2015, Volume 140, pp. 10 - 18
Since the discovery of leptin in 1994 by Zhang et al., there have been a number of reports showing its implication in the development of a wide range of... 
Cardiomyocytes | Metabolism | Viability | Leptin | Contractile function | Physiological aspects | Analysis
Journal Article
Journal Article
European Heart Journal, ISSN 0195-668X, 08/2013, Volume 34, Issue suppl 1, pp. P3257 - P3257
Journal Article
Endocrine, ISSN 1355-008X, 3/2016, Volume 51, Issue 3, pp. 551 - 555
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2012, Volume 7, Issue 6, p. e37505
Background: Heart failure (HF) involves alterations in metabolism, but little is known about cardiomyopathy-(CM)-specific or diabetes-independent alterations... 
OXIDATIVE CAPACITY | SKELETAL-MUSCLE | PROTEIN | MITOCHONDRIAL | TRANSPORTERS | MULTIDISCIPLINARY SCIENCES | ACTIVATED RECEPTOR-ALPHA | ENDOPLASMIC-RETICULUM STRESS | PROMOTER | FAILURE | DEFICIENCY | Heart Ventricles - cytology | Calcium Channels - metabolism | Calcium - metabolism | Humans | Middle Aged | Heart Failure - physiopathology | Immunoblotting | Male | DNA Primers - genetics | RNA, Messenger - metabolism | Case-Control Studies | CD36 Antigens - metabolism | Myocardium - metabolism | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | Statistics, Nonparametric | Female | Fatty Acids - metabolism | Real-Time Polymerase Chain Reaction | Gene Expression Regulation - genetics | Heat-Shock Proteins - metabolism | Gene Expression Regulation - physiology | Heart Failure - genetics | Heart Failure - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Transcription Factors - metabolism | Metabolic Networks and Pathways - genetics | PPAR alpha - metabolism | Proteins | Messenger RNA | Genes | Physiological aspects | Genetic aspects | Diabetes | Gene expression | T cells | Protein binding | Heart | Plasma | Correlation | Biomedical research | Transcription | Calcium | Laboratories | Cardiomyopathy | Calcium metabolism | Cytotoxicity | Lipids | Lymphocytes T | Alterations | Transgenic animals | Rodents | Oxidation | Protein transport | Cardiology | Heart diseases | Inositol 1,4,5-trisphosphate | Inositol 1,4,5-trisphosphate receptors | Heart failure | Diabetes mellitus | CD36 antigen | Metabolism | Patients | Fatty acids | Musculoskeletal system | Acids | Myocardium | Ligands | Peroxisome proliferator-activated receptors | Ventricle | Handling | Calci en l'organisme | Malalties del cor | Calcium in the body | Cardiologia | Expressió gènica
Journal Article
European Heart Journal, ISSN 0195-668X, 08/2013, Volume 34, Issue suppl 1, pp. 5869 - 5869
Journal Article
Journal of Biosciences, ISSN 0250-5991, 12/2016, Volume 41, Issue 4, pp. 643 - 658
Two-pore channels (TPCs or TPCNs) are novel voltage-gated ion channels that have been postulated to act as Ca2+ and/or Na+ channels expressed exclusively in... 
Life Sciences | Biomedicine, general | cardiomyocytes | knockout | Life Sciences, general | Microbiology | 2-DE-MALDI-MS | Zoology | LC-MALDI-MS | Plant Sciences | Cell Biology | TPCN1 | PROTEIN | ISOFORMS | TPC2 | IDENTIFICATION | SMOOTH-MUSCLE | NAADP | CALCIUM | BIOLOGY | DIFFERENTIATION | EXPRESSION | Calcium - metabolism | Phosphoglycerate Kinase - biosynthesis | Diabetes Mellitus, Type 2 - genetics | Humans | Fatty Acid-Binding Proteins - biosynthesis | Cardiovascular Diseases - pathology | Cardiovascular Diseases - genetics | Phosphopyruvate Hydratase - genetics | Myocardium - metabolism | Lipid Metabolism - genetics | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Calcium Channels - genetics | Diabetes Mellitus, Type 2 - complications | Phosphoglycerate Kinase - genetics | Cardiovascular Diseases - etiology | Glucose Transporter Type 4 - genetics | Gene Expression Regulation | Rats | Myocardium - pathology | Fatty Acid-Binding Proteins - genetics | Mice, Knockout | Myocytes, Cardiac - pathology | Phosphopyruvate Hydratase - biosynthesis | Animals | Fatty Acid Binding Protein 3 | Glucose Transporter Type 4 - biosynthesis | Proteomics | Myocytes, Cardiac - metabolism | Calcium Channels - biosynthesis | Mice | Diabetes Mellitus, Type 2 - pathology | Physiological aspects | Cell metabolism | Genetic aspects | Ion channels | Research | Heart cells
Journal Article
by Kobayashi, J and Yoshida, M and Tarui, S and Hirata, M and Takahashi, K and Naruse, K and Kasahara, S and Sano, S and Oh, H and Halbach, M and Peinkofer, G and Baumgartner, S and Krausgrill, B and Fatima, A and Hescheler, J and Saric, T and Mueller-Ehmsen, J and Kamakura, T and Makiyama, T and Sasaki, K and Hattori, T and Ohno, S and Yoshida, Y and Horie, M and Kimura, T and Guan, K and Streckfuss-Boemeke, K and Wolf, F and Azizian, A and Stauske, M and Tiburcy, M and Wagner, S and Maier, L. S and Zimmermann, W. H and Hasenfuss, G and Mehta, A and Sequiera, G. L and Sudibyo, Y and Jun, L and Wong, P and Liew, R and Shim, W and Dambrot, C and Braam, S. R and Freund, C. M. A. H and Van De Pas, S and Ward-Van Oostwaard, D and Atsma, D. E and Mummery, C. L and Shigeta, T and Kureishi Bando, Y and Aoyama, M and Monji, A and Mitsui, T and Cheng, X. W and Murohara, T and Saikawa, T and Nishio, S and Takahashi, N and Thuc, L. C and Saito, S and Fukui, A and Kume, O and Hara, M and Nakagawa, M and Teshima, Y and Radovits, T and Olah, A and Nemeth, B and Hidi, L and Birtalan, E and Kokeny, G and Szabo, G and Merkely, B and Rottlaender, D and Wolny, M and Motloch, L. J and Gebing, T and Reda, S and Hoppe, U. C and Feijoo-Bandin, S and Rodriguez-Penas, D and Garcia-Rua, V and Otero, M. F and Mosquera-Leal, A and Gonzalez-Juanatey, J. R and Lago, M. F and Dimitriadis, K and Tsioufis, C and Tsiachris, D and Kasiakogias, A and Psaltopoulou, T and Tzamou, V and Mazaraki, A and Andrikou, I and Pitsavos, C and Stefanadis, C and Mill, J. G and Rodrigues, S. L and Baldo, M. P and ... and on behalf of IRTG - 1566 PROMISE and on behalf of The SAVIOR investigators and on behalf of On behalf of the PLATelet inhibition and patient Outcomes (PLATO) investigators and on behalf of EPES Acute Cardiac Care group and on behalf of WHICH? Trial Investigators and on behalf of Prof. Geibel. PD Dr. Harloff, Dr. Guenther and on behalf of Italian ClinicalService Project and on behalf of PL-ACS Invaestigators and on behalf of EmbraceAC Study Group and on behalf of CHFN and on behalf of The interventional working group of the lebanese society of cardiology and on behalf of SAFETY Investigators and on behalf of grant of IGA Ministry of health of the Czech Republic no. NS9824-4/2008 and on behalf of the Korean Hypertension Research Network and on behalf of Jian-Jun Li and on behalf of the FRANCE2 steering Committee and on behalf of Cardiology&Development and on behalf of St. Antonius center for platelet function research and on behalf of the MANTRA Study investigators and on behalf of ROCKET AF Executive Committee and on behalf of Tako tsubo Italian Network and on behalf of the AF meta-analysis team and on behalf of Ibaraki Coronary Artery Disease Study (ICAS) registry and on behalf of ICALOR and on behalf of MANTRA Study Investigators and on behalf of Competence Network Heart Failure Germany and on behalf of APPRAISE-2 Study Group and on behalf of Sapaldia Study Group and on behalf of CHF-HOT Study and on behalf of CAPIRE Investigators and on behalf of Francesco Barilla, et al and on behalf of VIDA-IC investigators and on behalf of The BETTER-CARE Study Investigators and on behalf of BMIR and on behalf of The International Registry of Acute Aortic Dissection (IRAD) and on behalf of Francesca Frexia and on behalf of VIDA IC investigators and on behalf of FAST-MI 2010 and on behalf of Hypersleep and on behalf of ACTION and on behalf of SHIFT echostudy and on behalf of Korea Acute Myocardial Infarction Registry and on behalf of Barbanza investigators and on behalf of The GARFIELD Investigators and on behalf of the CHOICE trial investigators and on behalf of NIPPON DATA80/90 Research Group and on behalf of MINAP Steering Group and on behalf of PROTECT investigators and on behalf of TuePic and on behalf of Center for Clinical Heart Research, Oslo University Hospital, Ullevaal and on behalf of PROTECTION IV investigators and on behalf of ASAP Investigators and on behalf of FP7 project and on behalf of GARFIELD Investigators and on behalf of LIPID study investigators and on behalf of NIPPON DATA 80 Research Group and on behalf of COACH and on behalf of INH and on behalf of CARDIO-ARSIF registry and on behalf of Hopital Cardiologique, CIC a thematique cardiovasculaire CIC-005 INSERM, Universite Victor Segalen, CHU de Bordeaux, Bordeaux, France and on behalf of Registry of Cardiovascular Interventions, Czech Republic and on behalf of INPETU and on behalf of The International Registry of Acute Aortic Dissection and on behalf of the FAST-MI 2010 investigators and on behalf of PL-ACS Invastigators and on behalf of The Austrian Acute PCI Investigators and on behalf of Competence Network Heart Failure and on behalf of Thyroid Studies Collaboration and on behalf of University Centre for Cardiovascular Science and on behalf of SCAAR-registry and on behalf of BASKET/BASKET-PROVE Investigators and on behalf of Cardiac and on behalf of on behalf of the German Competence Network Heart Failure and the German Competence Network for HIV/AIDS and on behalf of Northern Iwate Heart Disease Registry Consortium and on behalf of J-MELODIC Investigators and on behalf of nil and on behalf of German Competence Network Heart Failure and on behalf of ARISTOTLE Investigators and on behalf of NA and on behalf of Popovici M
European Heart Journal, ISSN 0195-668X, 08/2012, Volume 33, Issue suppl 1, pp. 19 - 338
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 12/2019, Volume 170, p. 113677
The EMPA-REG OUTCOME (Empagliflozin, Cardiovascular Outcome Event Trial in patients with Type 2 Diabetes Mellitus (T2DM)) trial made evident the potentiality... 
Heart | Ceramides | Empagliflozin | Metabolomics | Sphingolipids | Glycerophospholipids
Journal Article
Journal Article